Cargando…
CD109, a TGF-β co-receptor, attenuates extracellular matrix production in scleroderma skin fibroblasts
INTRODUCTION: Scleroderma or systemic sclerosis (SSc) is a complex connective tissue disease characterized by fibrosis of skin and internal organs. Transforming growth factor beta (TGF-β) plays a key role in the pathogenesis of SSc fibrosis. We have previously identified CD109 as a novel TGF-β co-re...
Autores principales: | Man, Xiao-Yong, Finnson, Kenneth W, Baron, Murray, Philip, Anie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3446527/ https://www.ncbi.nlm.nih.gov/pubmed/22694813 http://dx.doi.org/10.1186/ar3877 |
Ejemplares similares
-
CD109 released from human bone marrow mesenchymal stem cells attenuates TGF-β-induced epithelial to mesenchymal transition and stemness of squamous cell carcinoma
por: Zhou, Shufeng, et al.
Publicado: (2017) -
CD47 prevents the elimination of diseased fibroblasts in scleroderma
por: Lerbs, Tristan, et al.
Publicado: (2020) -
Suppression of skin tumorigenesis in CD109-deficient mice
por: Sunagawa, Masaki, et al.
Publicado: (2016) -
CONNECTIVE TISSUE SYNTHESIS BY SCLERODERMA SKIN FIBROBLASTS IN CELL CULTURE
por: Leroy, E. Carwile
Publicado: (1972) -
CD109 acts as a gatekeeper of the epithelial trait by suppressing epithelial to mesenchymal transition in squamous cell carcinoma cells in vitro
por: Zhou, Shufeng, et al.
Publicado: (2019)